BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

740 related articles for article (PubMed ID: 23513502)

  • 1. [Inflammation of the optic nerve: when it should be considered as neuromyelitis optica--the experience of the Department of Neurology at Hadassah Hospital].
    Vaknin-Dembinsky A; Levin N; Raz N; Abramsky O; Karussis D; Brill L; Petrou P; Ovadia H
    Harefuah; 2013 Feb; 152(2):101-5, 122. PubMed ID: 23513502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NMO-IgG predicts the outcome of recurrent optic neuritis.
    Matiello M; Lennon VA; Jacob A; Pittock SJ; Lucchinetti CF; Wingerchuk DM; Weinshenker BG
    Neurology; 2008 Jun; 70(23):2197-200. PubMed ID: 18434643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microcystic inner nuclear layer abnormalities and neuromyelitis optica.
    Gelfand JM; Cree BA; Nolan R; Arnow S; Green AJ
    JAMA Neurol; 2013 May; 70(5):629-33. PubMed ID: 23529376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of visual acuity and automated perimetry findings in patients with neuromyelitis optica or multiple sclerosis after single or multiple attacks of optic neuritis.
    Fernandes DB; Ramos Rde I; Falcochio C; Apóstolos-Pereira S; Callegaro D; Monteiro ML
    J Neuroophthalmol; 2012 Jun; 32(2):102-6. PubMed ID: 22157535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuromyelitis optica and aquaporin-4 (AQP4) autoantibodies in consecutive optic neuritis patients in Southern Finland.
    Siuko M; Tienari PJ; Saastamoinen KP; Atula S; Miettinen A; Kivelä T; Setälä K
    Acta Ophthalmol; 2014 Jun; 92(4):387-91. PubMed ID: 23773223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuromyelitis optica-IgG in idiopathic inflammatory demyelinating disorders amongst Hong Kong Chinese.
    Chan KH; Ramsden DB; Yu YL; Kwok KH; Chu AC; Ho PW; Kwan JS; Lee R; Lim E; Kung MH; Ho SL
    Eur J Neurol; 2009 Mar; 16(3):310-6. PubMed ID: 19138340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of diagnostic value for NMO-IgG in patients with neuromyelitis optica].
    Yang Y; Huang DH; Wu L; Wu WP
    Zhonghua Yi Xue Za Zhi; 2010 Mar; 90(9):606-9. PubMed ID: 20450783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuromyelitis optica antibodies in patients with severe optic neuritis in China.
    Lai C; Tian G; Takahashi T; Liu W; Yang L; Zhang X
    J Neuroophthalmol; 2011 Mar; 31(1):16-9. PubMed ID: 21150455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantification of retinal neural loss in patients with neuromyelitis optica and multiple sclerosis with or without optic neuritis using Fourier-domain optical coherence tomography.
    Monteiro ML; Fernandes DB; Apóstolos-Pereira SL; Callegaro D
    Invest Ophthalmol Vis Sci; 2012 Jun; 53(7):3959-66. PubMed ID: 22589446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Recurrent inflammatory optic neuritis and neuromyelitis optica].
    de Sèze J; Arndt C
    Rev Neurol (Paris); 2010 Dec; 166(12):966-9. PubMed ID: 21126746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prognostic value of aquaporin-4 antibody in patients of inflammatory demyelinating diseases in central nervous system].
    Yang Y; Wu WP; Huang DH; Wu L
    Zhonghua Yi Xue Za Zhi; 2012 Nov; 92(43):3032-5. PubMed ID: 23328372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis and treatment of neuromyelitis optica.
    Wingerchuk DM
    Neurologist; 2007 Jan; 13(1):2-11. PubMed ID: 17215722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-risk syndrome for neuromyelitis optica: a descriptive and comparative study.
    Collongues N; Marignier R; Zéphir H; Blanc F; Vukusic S; Outteryck O; Fleury M; Ruet A; Borgel F; Thouvenot E; Moreau T; Defer G; Derache N; Pelletier J; Audoin B; Debouverie M; Labauge P; Gout O; Camu W; Brassat D; Brochet B; Vermersch P; Confavreux C; de Seze J
    Mult Scler; 2011 Jun; 17(6):720-4. PubMed ID: 21239412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seroprevalence of NMO-IgG among patients with neuromyelitis optica and opticospinal multiple sclerosis.
    Etemadifar M; Mollabashi M; Chitsaz A; Behnamfar O; Bahrami E; Minagar A; Maghzi AH
    Clin Neurol Neurosurg; 2012 Jan; 114(1):17-20. PubMed ID: 22014378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The limited demyelinating diseases: the voyage of optic neuritis and transverse myelitis to multiple sclerosis and neuromyelitis.
    Idiman E; Ozakbaş S
    Expert Rev Neurother; 2011 Mar; 11(3):451-62. PubMed ID: 21375450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aquaporin 4 antibody [NMO Ab] status in patients with severe optic neuritis in India.
    Ambika S; Balasubramanian M; Theresa L; Veeraputhiran A; Arjundas D
    Int Ophthalmol; 2015 Dec; 35(6):801-6. PubMed ID: 25682013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of neuromyelitis optica attack severity by quantitation of complement-mediated injury to aquaporin-4-expressing cells.
    Hinson SR; McKeon A; Fryer JP; Apiwattanakul M; Lennon VA; Pittock SJ
    Arch Neurol; 2009 Sep; 66(9):1164-7. PubMed ID: 19752309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of spectral domain optical coherence tomography measurements in optic neuritis: differences in neuromyelitis optica, multiple sclerosis, isolated optic neuritis and normal healthy controls.
    Park KA; Kim J; Oh SY
    Acta Ophthalmol; 2014 Feb; 92(1):e57-65. PubMed ID: 23889747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain abnormalities in neuromyelitis optica.
    Pittock SJ; Lennon VA; Krecke K; Wingerchuk DM; Lucchinetti CF; Weinshenker BG
    Arch Neurol; 2006 Mar; 63(3):390-6. PubMed ID: 16533966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neuromyelitis optica: a clinical update].
    Chiquete E; Navarro-Bonnet J; Ayala-Armas R; Gutiérrez-Gutiérrez N; Solórzano-Meléndez A; Rodríguez-Tapia D; Gómez-Rincón M; Ruiz-Sandoval JL
    Rev Neurol; 2010 Sep; 51(5):289-94. PubMed ID: 20669128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.